1.Stephen, EH, Chandra, A. Declining estimates of infertility in the United States: 1982–2002. Fertil. Steril. 2006; 86:516–523.
2.Jarow, JP, Espeland, MA, Lipshultz, LI. Evaluation of the azoospermic patient. J. Urol. 1989; 142:62–65.
3.Dohle, GR, Halley, DJ, Van Hemel, JO et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum. Reprod. 2002; 17:13–16.
4.Desai, N, Gill, P, Tadros, NN, et al. Azoospermia and embryo morphokinetics: testicular sperm-derived embryos exhibit delays in early cell cycle events and increased arrest prior to compaction. J. Assist. Reprod. Genet. 2018; 35:1339–1348.
5.Carpi, A, Sabanegh, E, Mechanick, J. Controversies in the management of nonobstructive azoospermia. Fertil. Steril. 2009; 91:963–970.
6.Singer, R, Sagiv, M, Barnet, M, Levinsky, H. Semen volume and fructose content of human semen. Survey of the years 1980–1989. Acta Eur. Fertil. 1990; 21:205–206.
7.Paick, J, Kim, SH, Kim, SW. Ejaculatory duct obstruction in infertile men. BJU Int. 2000; 85:720–724.
8.Roberts, M, Jarvi, K. Steps in the investigation and management of low semen volume in the infertile man. Can. Urol. Assoc. J. 2009; 3:479–485.
9.Schlegel, PN, Shin, D, Goldstein, M. Urogenital anomalies in men with congenital absence of the vas deferens. J. Urol. 1996; 155:1644–1648.
10.Hall, S, Oates, RD. Unilateral absence of the scrotal vas deferens associated with contralateral mesonephric duct anomalies resulting in infertility: laboratory, physical and radiographic findings, and therapeutic alternatives. J. Urol. 1983; 50:1161–1164.
11.Chillon, M, Casals, T, Mercier, B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N. Engl. J. Med. 1995; 332:1475–1480.
12.Yu, J, Chen, Z, Ni, Y, Li, Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum. Reprod. 2012; 27:25–35.
13.McCallum, T, Milunsky, J, Munarriz, R, et al. Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations. Hum. Reprod. 2001; 16:282–288.
14.Schwarzer, JU, Schwarz, M. Significance of CFTR gene mutations in patients with congenital aplasia of vas deferens with special regard to renal aplasia. Andrologia 2012; 44:305–307.
15.Meng, MV, Black, LD, Cha, I, et al. Impaired spermatogenesis in men with congenital absence of the vas deferens. Hum. Reprod. 2001; 16:529–533.
16.Friedler, S, Raziel, A, Schachter, M, et al. Outcome of first and repeated testicular sperm extraction and ICSI in patients with non-obstructive azoospermia. Hum. Reprod. 2002; 17:2356–2361.
17.Matsumiya, K, Namiki, M, Takahara, S, et al. Clinical study of azoospermia. Int. J. Androl. 1994; 17:140–142.
18.Faes, K, Goossens, E. Short-term storage of human testicular tissue: effect of storage temperature and tissue size. RBM Online 2017; 35:180–188.
19.Krege, S, Beyer, J, Souchon, R, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann. Oncol. 2004; 15:1377–1399.
20.Honig, SC, Lipshulz, LI, Jarow, J. Significant medical pathology uncovered by a comprehensive male infertility evaluation. Fertil. Steril. 1994; 62:1028–1034.
21.Shefi, S, Turek, PJ. Definition and current evaluation of subfertile men. Int. Braz. J. Urol. 2006; 32:385–397.
22.Dohle, GR, Elzanaty, S, van Casteren, NJ. Testicular biopsy: clinical practice and interpretation. Asian J. Androl. 2012; 14:88–93.
23.Donoso, P, Tournaye, H, Devroey, P. Which is the best sperm retrieval technique for nonobstructive azoospermia? A systematic review. Hum. Reprod. Update 2007; 13:539–549.
24.Schlegel, PN, Su, LM. Physiological consequences of testicular sperm extraction. Hum. Reprod. 1997; 12:1688–1692.
25.Pilatz, A, Rusz, A, Wagenlehner, F, Weidner, W, Altinkilic, B. Reference values for testicular volume, epididymal head size and peak systolic velocity of the testicular artery in adult males measured by ultrasonography. Ultraschall Med. 2013; 34:349–354.
26.Tsirigotis, M, Bennett, V, Nicholson, N, et al. Experience with subzonal insemination (SUZI) and intracytoplasmic sperm injection (ICSI) on unfertilized aged human oocytes. J. Assist. Reprod. Genet. 1994; 11:389–394.
27.Henkel, RR, Schill, WB. Sperm preparation for ART. Reprod. Biol. Endocrinol. 2003; 1:108–122.
28.Kovacic, B, Vlaisavljevic, V, Reljic, M. Clinical use of pentoxifylline for activation of immotile testicular sperm before ICSI in patients with azoospermia. J. Androl. 2006; 27:45–52.
29.Caroppo, E, Colpi, EM, Gazzano, G, et al. Testicular histology may predict the successful sperm retrieval in patients with non-obstructive azoospermia undergoing conventional TESE: a diagnostic accuracy study. J. Assist. Reprod. Genet. 2017; 34:149–154.
30.Selice, R, Di Mambro, A, Garolla, A, et al. Spermatogenesis in Klinefelter syndrome. J. Endocrinol. Invest. 2010; 33:789–793.
31.Ostad, M, Liotta, D, Ye, Z, Schlegel, PN. Testicular sperm extraction for nonobstructive azoospermia: results of a multibiopsy approach with optimized tissue dispersion. Urology 1998; 52:692–696.
32.Schlegel, PN, Li, PS. Microdissection TESE: sperm retrieval in non-obstructive azoospermia. Hum. Reprod. Update 1998; 4:439.
33.Schlegel, PN. Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum. Reprod. 1999; 14:131–135.
34.Turunc, T, Gul, U, Haydardedeoglu, B, et al. Conventional testicular sperm extraction combined with the microdissection technique in nonobstructive azoospermic patients: a prospective comparative study. Fertil. Steril. 2010; 94:2157–2160.
35.Jensen, CFS, Ohl, DA, Hiner, MR, et al. Multiple needle-pass percutaneous testicular sperm aspiration as first line treatment in azoospermic men. Andrology 2016; 4:257–262.
36.Eliveld, J, van Wely, M, Meibner, A, et al. The risk of TESE-induced hypogonadism: a systematic review and meta-analysis. Hum. Reprod. Update 2018; 24:442–454.
37.Kalsi, J, Thum, MY, Muneer, A, Abdullah, H, Minhas, S. In the era of micro-dissection sperm retrieval (m-TESE) is an isolated testicular biopsy necessary in the management of men with non-obstructive azoospermia? BJU Int. 2012; 109:418–424.
38.Bernie, AM, Mata, DA, Ramasamy, R, Schlegel, PN. Comparison of microdissection testicular sperm extraction, conventional testicular sperm extraction, and testicular sperm aspiration for nonobstructive azoospermia: a systematic review and meta-analysis. Fertil. Steril. 2015; 104:1099–1103.
39.Deruyver, Y, Vanderschueren, D, Van der Aa, F. Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology 2014; 2:20–24.
40.Caroppo, E, Colpi, EM, Gazzano, G, et al. The seminiferous tubule caliber pattern as evaluated at high magnification during microdissection testicular sperm extraction predicts sperm retrieval in patients with nonobstructive azoospermia. Andrology 2019; 7:8–14.
41.Amer, M, Zohdy, W, Abd El Naser, T, et al. Single tubule biopsy: a new objective microsurgical advancement for testicular sperm retrieval in patients with nonobstructive azoospermia. Fertil. Steril. 2008; 89:592–596.
42.Hussein, A, Ozgok, Y, Ross, L, Niederberger, C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J. Androl. 2005; 26:787–791; discussion 792–793.
43.Shiraishi, K, Ohmi, C, Shimabukuro, T, Matsuyama, H. Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia. Hum. Reprod. 2012; 27:331–339.
44.Reifsnyder, JE, Ramasamy, R, Husseini, J, Schlegel, PN. Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia. J. Urol. 2012; 188:532–536.
45.Esteves, SC, Miyaoka, R, Roque, M, Agarwal, A. Outcome of varicocele repair in men with nonobstructive azoospermia: systematic review and meta-analysis. Asian J. Androl. 2016; 18:246–253.
46.Kirby, EW, Wiener, LE, Rajanahally, S, Crowell, K, Coward, RM. Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis. Fertil. Steril. 2016; 106:1338–1343.
47.Ramasamy, R, Yagan, N, Schlegel, PN. Structural and functional changes to the testis after conventional versus microdissection testicular sperm extraction. Urology 2005; 65:1190–1194.
48.Tournaye, H, Verheyen, G, Nagy, P, et al. Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? Hum. Reprod. 1997; 12:80–86.
49.Verhoeven, G, Cailleau, J. Follicle-stimulating hormone and androgens increase the concentration of the androgen receptor in Sertoli cells. Endocrinology 1988; 122:1541–1550.
50.Kim, ED, Crosnoe, L, Bar-Chama, N, Khera, M, Lipshultz, L. The treatment of hypogonadism in men of reproductive age. Fertil. Steril. 2013; 99:718–724.
51.Pitteloud, N, Hayes, FJ, Dwyer, A, et al. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2002; 87:4128–4136.
52.Adamopoulos, DA, Pappa, A, Billa, E, et al. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. Fertil. Steril. 2003; 80:914–920.
53.Rodrigo, L, Rubio, C, Peinado, V, et al. Testicular sperm from patients with obstructive and nonobstructive azoospermia: aneuploidy risk and reproductive prognosis using testicular sperm from fertile donors as control samples. Fertil. Steril. 2011; 95:1005–1012.
54.Vozdova, M, Heracek, J, Sobotka, V, Rubes, J. Testicular sperm aneuploidy in non-obstructive azoospermic patients. Hum. Reprod. 2012; 27:2233–2239.
55.Schlegel, PN. Male infertility: evaluation and sperm retrieval. Clin. Obstet. Gynecol. 2006; 49:55–72.
56.Samli, H, Samli, MM, Solak, M, Imirzalioglu, N. Genetic anomalies detected in patients with non-obstructive azoospermia and oligozoospermia. Arch. Androl. 2006; 52:263–267.
57.Pryor, JL, Kent-First, M, Muallem, A, et al. Microdeletions in the Y chromosome of infertile men. N. Engl. J. Med. 1997; 336:534–539.
58.Oates, RD, Silber, S, Brown, LG, Page, DC. Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the Y chromosome, and of 18 children conceived via ICSI. Hum. Reprod. 2002; 17:2813–2824.
59.Hopps, CV, Mielnik, A, Goldstein, M, et al. Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. Hum. Reprod. 2003; 18:1660–1665.
60.Lee, SH, Ahn, SY, Lee, KW, et al. Intracytoplasmic sperm injection may lead to vertical transmission, expansion, and de novo occurrence of Y-chromosome microdeletions in male fetuses. Fertil. Steril. 2006; 85:1512–1515.
61.Practice Committee for the ASRM. Evaluation of the azoospermic male: a committee opinion. Fertil. Steril. 2018; 109:777–782.